MARATTO

article · International Journal of Molecular Sciences

Plasmodium knowlesi Heat Shock Protein 90s: In Silico Analysis Reveals Unique Druggable Structural Features

20251 citationOpen accessRhodes University

Abstract

The increasing threat of zoonotic malaria parasites of humans, such as Plasmodium knowlesi, make the search for improved pharmacotherapy imperative. Using protein sequence and structural analyses, phylogenetics, protein network mapping, protein–ligand interaction, and small molecule docking studies, we have identified for the first time the predicted structure, function, and druggability of the P. knowlesi heat shock protein 90s (PkHsp90s). Four isoforms were identified (in the cytosol, endoplasmic reticulum, mitochondrion, and apicoplast), and key structural differences were elucidated compared to human Hsp90s. In particular, the glycine-rich helix loop (GHL) motif of cytosolic PkHsp90 was predicted to have a straight conformation that forms a plasmodial-specific hydrophobic extension of the lid domain of the ATP-binding site, which was not observed for the cytosolic human Hsp90s, HSPC1 (Hsp90α), and HSPC3 (Hsp90β). Virtual screening identified for the first time a number of compounds from the ZINC database (ZINC22007970, ZINC724661072, and ZINC724661078) that were predicted to bind strongly to the GHL-associated pocket of PkHsp90, with weak or no binding to HSPC1. This study has provided a molecular framework in support of rational drug design, targeting PkHsp90s as a promising route for antimalarial drug development in the fight against zoonotic malaria.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/ijms262412065

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.